Crosscheck

Your medical. Crosschecked.

Other

Mitomycin (intravesical)

Maintenance intravesical treatment on the FAA's bladder cancer worksheet

Taken for: Bladder cancerTaking it for something else? The entries here do not cover that use. The FAA may address it in the guidance for your condition. Ask your examiner.

FAA guidance

Acceptable with conditions.

Wait

24 hours

no-fly after each treatment, and asymptomatic

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

Source: FAA, CACI – Bladder Cancer Worksheet. FAA date 27 April 2022. Checked by Crosscheck 14 October 2026

For bladder cancer, the FAA's CACI – Bladder Cancer Worksheet lists, as current treatment, none or maintenance intravesical BCG or mitomycin, and says that if these medications are used, the airman should not fly until 24 hours post treatment and asymptomatic.

Track your medications
More detail: mitomycin (intravesical)The rest of Crosscheck's reading, in plain wordsOpen

The same row says that if the airman is currently on chemotherapy or radiation treatment, the exam is deferred, and that if it has been 5 or more years since any treatment for the condition, with no history of metastatic disease and no reoccurrence, CACI is not required. The worksheet applies with all its other criteria, and the examiner must note in Block 60 one of its statements, which include CACI qualified bladder cancer, and not CACI qualified and deferred.

  • 24 hours after each dose: no flying
Show the FAA's words: mitomycin (intravesical)The official FAA wording: one passage, each with its document and dateOpen
FAA, CACI – Bladder Cancer Worksheet · FAA date 27 April 2022
CACI – Bladder Cancer Worksheet
AME MUST NOTE in Block 60 one of the following:
CACI qualified bladder cancer. (Documents do not need to be submitted to the FAA.)
NOT CACI qualified bladder cancer. I have deferred.
Current treatment
Notes: If it has been 5 or more years since the airman has had any treatment for this condition, with no history of metastatic disease, and no reoccurrence, CACI is not required.
If the airman is currently on chemotherapy or radiation treatment, defer the exam.
None or maintenance intravesical BCG or mitomycin.
(If these medications are used, the airman should not fly until 24 hours post treatment and asymptomatic.)
Sources and dates: mitomycin (intravesical)One FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

  • Bladder cancer

    Check a condition: what the FAA's documents say the examiner looks at
  • BCG (intravesical)

    Maintenance intravesical treatment on the FAA's bladder cancer worksheet
  • Other medications

    Every medication in this group, with its answer and wait

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.